Indeed, in previous work, it was reported that a UHCL3 inhibitor was identified and could be further applied in treating non-small lung cancer, breast cancer and lung cancer;35,52 however, whether the suppressive effect of these inhibitors on UHCL3 occurs through the direct binding and targeting of UCHL3 remains to be determined. This evidence concerns the gene UCHL3 and lung carcinoma.